The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes modest amounts,
As suggested further director buys. Expect this to continue.
More inside buying. Pleasing to see. Despite my better judgement, and before this RNS came out, I decided to take a final tranche myself. That is my lot here now. GLA.
"They will need to dilute shareholders soon"
Did you just feel the need to post something for the sake of it or you are just hoping others can't read the RNS? (Did you?)
Company restructuring update:
"Cash runway extended into 2024"
"Headcount reduced by 40%"
It will multiply from lows Do some research and look what can be achieved here
Myles quick pump and dump sold already?
The rise this morning is due to Myles buying in and he has a large following. Also I am expecting further director buys, which should help.
How much is the monthly cash burn anyone?
Could well be but if they can get a deal tie up that would help matters, question is how far away are they from a deal and will they need a raise by the time they get one
Well known twitter tipster bought in reason 4 rise, as a trade
Broker values +60p on deal
Hi Terry,
Take it you didn't read the recent RNS....
Headcount has been reduced by 40%, the overall variable costs of the business lowered and, as a result, the cash runway now extends into 2024
Well director buys so what do they know?
Hi,
Do you think this is a manufactured rise? Almost twice the 3 month average volume which is a lot given the volumes sold in December. You are probably right, it is difficult to believe that good news has leaked out to a rapturous waiting investment community. I’m still 86% down. Hey ho.
Well there do appear to be quite a few chunky sales of 50,000 or so this morning, hence the further strengthening of the SP. Hopefully a sign of good things to come!
I think they will buy in these small amounts but often.
In fairness, that is two Directors now....although still a few hundred thousand shares short of a purchase size that would encourage me to buy more personally. I agree with theoldmansdoneit's sentiment on this. Better than no purchases though, which makes them more worthy of respect than 90% of AIM BODs for this alone, IMO. I really hope they get a big return on it. Which would also result in me perhaps getting my own small stake back. Who knows? One deal and we might even make a small profit here, although given the cash runway, this is the spin of a roulette wheel now. Again IMO. GLA.
Interesting what one relatively small share purchase from a Board member will do to the share price! Makes you wonder what would happen if there was some definitively good news...
Whilst partnering appears the right and only route, our noval exosome delivery mechanism is possibly a decade away from FDA approval. So I guess the sixty four million dollar question is, does Mr Ross continue to try and fund Rene by various means for that period; something that many, including institutions, may have little appetite for given the experience of the last decade or does he try to sell?
The question then of course is to who and at what price? Novel therapies become exponentially more valuable over time but we don’t appear to be anywhere near a Phase 1 trial so what price would Ross and his Board off load the stock for? Sadly I haven’t the inside track of some so I’ve no idea but possibly dimes not dollars!
I still have faith that Iain will turn this ship around - if anyone can, he can, IMO...but it will take a much larger buy than that for me to add to my own position here. He bought bigger numbers of shares previously and at much higher prices, after all.
I agree theoldmansdoneit. Was thinking exact same things.
Guessing his purchase was the 9.5 trade @ 10:34 today.
Worth keeping an eye on.
I see that our executive Chairman Iain Ross has bought 100,000 shares today. It only amounts to c. £10,000 so not an overwhelming vote of confidence. If he’d bought a million I’d be more reassured. Still, if we could get a commercial deal or two over the line, it could easily be a ten bagger for him from these lowly levels.
LOL, I like your sense of humour Surprised.
Thanks Sajy, it’s good to have you back! It’s clear you’ve an inside track, a direct wire into Mr Ross’ office; in future it would be useful if you could as a result give us a heads up in advance of these RNS’. Thanks in anticipation.
My thoughts after this mornings Rns. Cash runway into 2024, which is a start, but I would like to see the hRPC data package sold for a few million and last I heard was that quite a few companies were interested. A few million should come from the Fosun partnerships. That should extend runway into mid 2024. I should point out that Fosun are paying the wages of a few of our staff as part of the deal. Regarding the exosomes our costs are paid for by partners and with no trials running our cash burn should be much lower this year. That should give them plenty of time to prove up the data and sign at least one exosome deal this year. We just need to get one deal over the line with a decent upfront payment and that will be transformational for the company. I still hold all my shares and believe Iain will turn it around, he is not going anywhere until he has. GLA.